ARTICLE | Company News
FDA panel to discuss Pradaxa
August 27, 2010 11:48 PM UTC
FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on Sept. 20 to discuss an NDA for Pradaxa dabigatran from Boehringer Ingelheim GmbH (Ingelheim, Germany) to prevent stroke in patients...